Safety and delivery efficiency of a photodynamic treatment of the lungs using indocyanine green and extracorporeal near infrared illumination

Giulia Kassab, Vsevolod Cheburkanov, Jace Willis, Madeleine G. Moule, Cristina Kurachi, Vladislav Yakovlev, Jeffrey D. Cirillo, Vanderlei S. Bagnato

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Photodynamic inactivation (PDI) is a promising alternative for combating infections caused by antimicrobial resistant bacteria. Pneumonias are among the most worrisome infections because of their high‐mortality rate. Previous studies have demonstrated the feasibility of using PDI with extracorporeal light to treat pneumonia. In this study, we analyzed key parameters for the viability of this treatment, including the selectivity of the photodynamic response for pathogens over host cells. Our results showed that PDI can induce killing of Staphylococcus aureus (of up to 4.18 log for the strain Xen29 and 3.62 log for Xen36) under conditions where little or no toxicity for host cells is observed. We validated pulmonary delivery of the photosensitizer and light in mice, using photobleaching as an indicator, and demonstrated preservation of healthy tissues as evidence of the safety of the protocol. Overall, PDI displays low toxicity on host tissues, making it a promising tool for treatment of pneumonias caused by S. aureus and other important pathogens.
Original languageEnglish
JournalJournal of biophotonics
DOIs
Publication statusPublished - 15 Jul 2020

Keywords / Materials (for Non-textual outputs)

  • indocyanine green
  • photodynamic inactivation
  • pulmonary delivery
  • safety
  • selective toxicity

Fingerprint

Dive into the research topics of 'Safety and delivery efficiency of a photodynamic treatment of the lungs using indocyanine green and extracorporeal near infrared illumination'. Together they form a unique fingerprint.

Cite this